ClinicalTrials.Veeva

Menu

Prospective Cohort Study of Association of Insulin Resistance/Steatosis With Hepatic Fibrosis in CHB and NAFLD

S

Seoul National University Boramae Hospital

Status

Completed

Conditions

Fatty Liver
Chronic Hepatitis B
Hepatic Fibrosis

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Hepatic steatosis and insulin resistance are associated with severity of fibrosis in non-alcoholic fatty liver disease (NAFLD) and chronic hepatitis C. However, clinical significance of steatosis and insulin resistance on fibrosis in chronic hepatitis B (CHB) is not well established. The aim was to investigate the relationship between insulin resistance, hepatic steatosis, and fibrosis in patients with CHB.

Full description

acoustic radiation force impulse elastography

Enrollment

500 patients

Sex

All

Ages

20 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Chronic hepatitis B patients
  • With evidences of hepatic steatosis on ultrasonography or pathology

Exclusion criteria

  • significant alcohol consumption or other known liver diseases

Trial design

500 participants in 2 patient groups

HBV without FL
Description:
Chronic hepatitis B without steatosis
HBV with FL
Description:
Chronic hepatitis B patients with steatosis

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems